Market Tracker

01/19 5:15pm ET

Novelion Therapeutics Inc (NASDAQ:NVLN)

4.09
Delayed Data
As of Jan 19
 0.00 / 0.00%
Today’s Change
3.08
Today|||52-Week Range
12.12
+31.09%
Year-to-Date
No recent news for Novelion Therapeutics Inc.

Today’s Trading

Previous close4.09
Today’s open3.83
Day’s range3.82 - 4.09
Volume25,604
Average volume (3 months)85,053
Market cap$76.3M
Data as of 3:59pm ET, 01/19/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+85.82%
Earnings growth (next 5 years)+74.60%
Revenue growth (last year)--
P/E ratioNM
Price/Sales7.00
Price/Book0.56

Competitors

 Today’s
change
Today’s
% change
CDTXCidara Therapeutics ...0.000.00%
CTSOCytosorbents Corp0.000.00%
CDXCChromadex Corp0.000.00%
NATRNatures Sunshine Pro...0.000.00%
Data as of 4:00pm ET, 01/19/2018

Financials

Next reporting dateMarch 14, 2018
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$13.6M
Annual profit (last year)-$52.9M
Net profit margin-389.49%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Operating Officer &
Executive VP
Jeffrey Hackman
Chief Financial Officer &
Senior Vice President
Michael Dennis Price
Corporate headquarters
Vancouver, British Columbia

Forecasts